BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22679444)

  • 21. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac.
    Chen Z; Gettie A; Ho DD; Marx PA
    Virology; 1998 Jun; 246(1):113-24. PubMed ID: 9656999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rhesus monkey TRIM5α SPRY domain recognizes multiple epitopes that span several capsid monomers on the surface of the HIV-1 mature viral core.
    Biris N; Tomashevski A; Bhattacharya A; Diaz-Griffero F; Ivanov DN
    J Mol Biol; 2013 Dec; 425(24):5032-44. PubMed ID: 23886867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of RING domain to retrovirus restriction by TRIM5alpha depends on combination of host and virus.
    Maegawa H; Miyamoto T; Sakuragi J; Shioda T; Nakayama EE
    Virology; 2010 Apr; 399(2):212-20. PubMed ID: 20110098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct combinations of amino acid substitutions in N-terminal domain of Gag-capsid afford HIV-1 resistance to rhesus TRIM5α.
    Nomaguchi M; Nakayama EE; Yokoyama M; Doi N; Igarashi T; Shioda T; Sato H; Adachi A
    Microbes Infect; 2014 Nov; 16(11):936-44. PubMed ID: 25195168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of TRIM5α RING domain E3 ubiquitin ligase activity in capsid disassembly, reverse transcription blockade, and restriction of simian immunodeficiency virus.
    Kim J; Tipper C; Sodroski J
    J Virol; 2011 Aug; 85(16):8116-32. PubMed ID: 21680520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TRIM5alpha Modulates Immunodeficiency Virus Control in Rhesus Monkeys.
    Lim SY; Rogers T; Chan T; Whitney JB; Kim J; Sodroski J; Letvin NL
    PLoS Pathog; 2010 Jan; 6(1):e1000738. PubMed ID: 20107597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adaptation of HIV-1 to cells expressing rhesus monkey TRIM5α.
    Pacheco B; Finzi A; Stremlau M; Sodroski J
    Virology; 2010 Dec; 408(2):204-12. PubMed ID: 20956011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TRIM5α and Species Tropism of HIV/SIV.
    Nakayama EE; Shioda T
    Front Microbiol; 2012; 3():13. PubMed ID: 22291694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A B-box 2 surface patch important for TRIM5alpha self-association, capsid binding avidity, and retrovirus restriction.
    Diaz-Griffero F; Qin XR; Hayashi F; Kigawa T; Finzi A; Sarnak Z; Lienlaf M; Yokoyama S; Sodroski J
    J Virol; 2009 Oct; 83(20):10737-51. PubMed ID: 19656869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.
    Stremlau M; Owens CM; Perron MJ; Kiessling M; Autissier P; Sodroski J
    Nature; 2004 Feb; 427(6977):848-53. PubMed ID: 14985764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simian Immunodeficiency Virus SIVmac239, but Not SIVmac316, Binds and Utilizes Human CD4 More Efficiently than Rhesus CD4.
    Fellinger CH; Gardner MR; Bailey CC; Farzan M
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28679752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecularly cloned SIVmac.
    Naidu YM; Kestler HW; Li Y; Butler CV; Silva DP; Schmidt DK; Troup CD; Sehgal PK; Sonigo P; Daniel MD
    J Virol; 1988 Dec; 62(12):4691-6. PubMed ID: 2846880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Removal of arginine 332 allows human TRIM5alpha to bind human immunodeficiency virus capsids and to restrict infection.
    Li Y; Li X; Stremlau M; Lee M; Sodroski J
    J Virol; 2006 Jul; 80(14):6738-44. PubMed ID: 16809279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-retroviral activity of TRIM5 alpha.
    Nakayama EE; Shioda T
    Rev Med Virol; 2010 Mar; 20(2):77-92. PubMed ID: 20049904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
    Wang J; Shaban NM; Land AM; Brown WL; Harris RS
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29618650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of TRIM5α polymorphism on HIV-2ROD and SIVmac239 replication in PBMCs from Chinese rhesus macaques and Vietnamese-origin cynomolgus macaques.
    Zhang HL; Liu FL; Jin YB; Deng Q; Liu BL; Zhuo M; Liu XH; Zheng YT; Ling F
    Virology; 2016 Jan; 487():222-9. PubMed ID: 26550946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrovirus restriction by TRIM5alpha variants from Old World and New World primates.
    Song B; Javanbakht H; Perron M; Park DH; Stremlau M; Sodroski J
    J Virol; 2005 Apr; 79(7):3930-7. PubMed ID: 15767395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of monoclonal antibodies that distinguish simian immunodeficiency virus isolates from each other and from human immunodeficiency virus types 1 and 2.
    Sutjipto S; Kodama T; Yee J; Gettie A; Jennings M; Desrosiers RC; Marx PA
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():247-9. PubMed ID: 1689369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure of the rhesus monkey TRIM5α PRYSPRY domain, the HIV capsid recognition module.
    Biris N; Yang Y; Taylor AB; Tomashevski A; Guo M; Hart PJ; Diaz-Griffero F; Ivanov DN
    Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13278-83. PubMed ID: 22847415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for a different susceptibility of primate lentiviruses to type I interferons.
    Cordeil S; Nguyen XN; Berger G; Durand S; Ainouze M; Cimarelli A
    J Virol; 2013 Mar; 87(5):2587-96. PubMed ID: 23255800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.